Amifostine in clinical oncology: current use and future applications.
about
Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trialsNormal tissue radioprotection by amifostine via Warburg-type effectsThe cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.Efficacy and tolerability of amifostine in elderly cancer patientsAmifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions.Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications.Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.Overview of the clinical efficacy of investigational anticancer drugs.Toxicity of platinum compounds.Protective Effect of Lycium ruthenicum Murr. Against Radiation Injury in MiceThe diverse and complex roles of radiation on cancer treatment: therapeutic target and genome maintenance.Radiation damage and radioprotectants: new concepts in the era of molecular medicineChemical genoprotection: reducing biological damage to as low as reasonably achievable levels.Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study.The influence of amifostine administration prior to cyclophosphamide on in vitro maturation of mouse oocytes.Quercetin liposomes protect against radiation-induced pulmonary injury in a murine model.Assessment of tissue redox status using metabolic responsive contrast agents and magnetic resonance imaging.Increased survival after irradiation followed by regeneration of bone marrow stromal cells with a novel thiol-based radioprotector.Protective effect of amifostine on busulfan induced DNA damage in human hepatoma cells.γ-Tocotrienol prevents 5-FU-induced reactive oxygen species production in human oral keratinocytes through the stabilization of 5-FU-induced activation of Nrf2.Biological determinants of radioresistance and their remediation in pancreatic cancer.Current trends in the management of oral mucositis related to cancer treatment.L-Carnitine Protection Against Cisplatin Nephrotoxicity In Rats: Comparison with Amifostin Using Quantitative Renal Tc 99m DMSA Uptake.Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.The effect of amifostine, a cytoprotective agent, on paraquat toxicity in mice.Oxidative study of patients with total body irradiation: effects of amifostine treatment.Stevens-Johnson syndrome after amifostine during radiotherapy.Radioprotection in mice following oral delivery of amifostine nanoparticles.Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine.Effects of yak-activated protein on hematopoiesis and related cytokines in radiation-induced injury in mice.Structural and functional damages of whole body ionizing radiation on rat brain homogenate membranes and protective effect of amifostine.Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation.A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.Radiation mitigation effect of cultured mushroom fungus Hirsutella Sinensis (CorImmune) isolated from a Chinese/Tibetan herbal preparation -Cordyceps Sinensis.[Effect of amifostine on locally advanced non-small cell lung cancer patients treated with radiotherapy: a meta-analysis of randomized controlled trials].
P2860
Q28538411-AFE205C2-894B-47DB-8060-5034431AA976Q28830846-C04E1531-936D-432F-ABFE-6DB34478DDEBQ33545423-4CBF9414-D522-4DAF-9735-CE3B8049DA01Q33638876-A171C41F-11BF-4185-8941-E8D2E640BC72Q33738758-9294CB5A-30C5-469C-8CCA-C1794DB80379Q34168634-DA5861F1-4D95-4882-A0FD-E73E8F9A820BQ34984599-0CEA2675-AA84-4C5C-BA08-AC255BFC737EQ35031828-7521169A-2ECC-4645-B7F9-FFCF8C0F1772Q35067125-80C456E6-E71A-4F2D-8BC2-6C3F87ACC207Q35143947-F44003DA-9615-49DC-AC1E-145E1A9FE68DQ35891063-DE179920-9E92-40AF-B7A9-B83B04817BEAQ36135801-8024C3FB-A38C-467F-910D-34531AA66EF7Q36364394-48C0D6EF-8D55-4A08-B92B-7906295E2A79Q36461281-DA368DCE-710F-4D97-A433-3F4636CBB4D2Q36891296-0A5ECBCE-2581-4FC5-A531-DDB9A491C557Q37049967-E3CE17C3-D118-4546-8F0C-CF5B643CE10CQ37211831-773D8F6B-9FE6-4DD4-A0FE-2DC92A3E028EQ37222800-662CC833-F988-4D45-BB3F-7EF42524337CQ37620975-1D1FC583-6386-4B36-8E2E-03E44D0E180EQ38738226-E20C87F4-FBB0-4299-976D-FF49CA71BC65Q38916036-7B954D4F-8015-4129-8083-1B9B080E6144Q39156722-D05E3F0B-32F9-4352-B02D-B9F3E692E560Q40076594-E4F4B918-6CDD-496F-BA65-F1AEA64CC3A6Q41491887-B261CE08-8867-46AF-8F04-E5F872862677Q42130904-C07250E6-8DC2-476A-B6F6-105CB9CE2526Q42868602-8136C0E2-8A84-4C1A-B59D-7627ADC987CCQ44780695-C96E4D05-C4AA-4A55-95F6-375989B795D0Q44847883-FAADCB26-8FDA-4DBF-8AD9-B0978C8C8852Q46601074-AC156B54-B030-409B-8A84-C41057ECDA23Q46601277-8EA62640-B4C4-4C3C-A56B-9EFF4D61CD23Q47116685-750B865C-0A69-4F49-ACDF-E2F23E8207AFQ48536553-04E2CBA6-FEB8-4373-B2E0-96A2DD097799Q51789305-C3E53F02-FA82-49EC-B4D7-867A37708787Q52560942-EE6E8442-F083-4B8B-967B-981883F95074Q53500578-E51EF78D-DD8D-4FCD-AA25-B429D35EBD5DQ55429590-0A4A59DA-4E4B-4C63-A957-CA0F3DCE9511
P2860
Amifostine in clinical oncology: current use and future applications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Amifostine in clinical oncology: current use and future applications.
@ast
Amifostine in clinical oncology: current use and future applications.
@en
Amifostine in clinical oncology: current use and future applications.
@nl
type
label
Amifostine in clinical oncology: current use and future applications.
@ast
Amifostine in clinical oncology: current use and future applications.
@en
Amifostine in clinical oncology: current use and future applications.
@nl
prefLabel
Amifostine in clinical oncology: current use and future applications.
@ast
Amifostine in clinical oncology: current use and future applications.
@en
Amifostine in clinical oncology: current use and future applications.
@nl
P1433
P1476
Amifostine in clinical oncology: current use and future applications.
@en
P2093
Koukourakis MI
P304
P356
10.1097/00001813-200203000-00001
P577
2002-03-01T00:00:00Z